Phil is a microbiologist with over 20 years’ experience in clinical, industrial and pharmaceutical industries. He has extensive knowledge in managing and operating QC microbiological and analytical laboratories at manufacturing sites for both synthetic and biologic products. He is currently the Business Process Owner for Microbiology in Quality and is responsible to strategy, standardization and issue management at AstraZeneca.
Phil is an active member of the Parenteral Drug Association, the Pharmaceutical Microbiology Expert Discussion Group and volunteer member of the USP Microbiology Expert Committee.
With an ever-increasing focus on sustainability across the pharmaceutical industry, many companies are looking to recombinant methods for bacterial endotoxin testing. During this panel discussion, experts will discuss the latest guidelines and regional variations on recombinant Factor C (rFC) and recombinant Cascade Reagents (rCR). Make sure you join to:
SME Testing Services
Lonza
Chief Microbiologist, Global Quality
AstraZeneca
Deputy Head Microbiology Safety Section
Paul-Ehrlich-Institut
Senior Principal Scientist
Merck Research Laboratories
Head of QA GxP Compliance and Sterility Assurance
Bio Products Laboratory
© Copyright 2024 Russell Publishing Limited.
All Rights Reserved.
Registered address: Court Lodge, Hogtrough Hill, Brasted, Kent, TN16 1NU, United Kingdom
Company registration number: 2709148
+44 (0)1959 563 311
[email protected]
Access the latest news, articles, interviews and insights at European Pharmaceutical Review
